Kim Chi MD, Medical Oncologist, Senior Scientist at the BC Cancer Agency explains what came out of the metastatic castration-sensitive prostate cancer (mCSPC) TITAN study.
TITAN Study Presented at ASCO 2019
Kim Chi MD, Medical Oncologist, Senior Scientist at the BC Cancer Agency explains what came out of the metastatic castration-sensitive prostate cancer (mCSPC) TITAN study.